Whittier Trust CO Bio N Tech Se Transaction History
Whittier Trust CO
- $7.47 Billion
- Q4 2024
A detailed history of Whittier Trust CO transactions in Bio N Tech Se stock. As of the latest transaction made, Whittier Trust CO holds 52 shares of BNTX stock, worth $6,082. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52
Previous 52
-0.0%
Holding current value
$6,082
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$962 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$516 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$503 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$222 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$211 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...